Breast Cancer Drugs Recommended by U.S. for High-Risk Women
This article is for subscribers only.
Some women who are at high risk of breast cancer, including those with a family history of the disease, should consider taking drugs to reduce their chances of getting cancer, a U.S. health advisory group said.
The drugs, tamoxifen and raloxifene, carry risks such as blood clots, stroke and cataracts, according to the U.S. Preventive Services Task Force, which released the draft recommendations on its website. The proposal is open for public comment until May 13.